Two weeks ago, I attended the American Academy of Allergy, Asthma, and Immunology Conference, or Quad AI, in Washington, D.C. I was able to spend time with some of the most important leaders in the allergy space, both advocacy leaders and clinical leaders, who spend their days focused on better serving patients at risk for anaphylaxis.

Mar 6, 2024 / CEO / receipt, needs a key / Dan Barber, CEO | earnings call 2024-03-06 | transcript b6117b1c-a352-4c5f-8006-93a3be34833e | chars 6547-6884 | segment 6